ARCA biopharma approves 1-for-12 reverse stock split

seekingalpha08-24

Pharmaceutical company ARCA biopharma (NASDAQ:ABIO) said on Friday its board has approved a reverse stock split of its shares at a ratio of 1-for-12. ARCA’s (ABIO) stock is expected to begin trading ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2461037529?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1301873080/image_1301873080.jpg","is_english":true,"pubTime":"2024-08-24 05:37","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2461037529","market":"nz","top_or_hot":-1,"title":"ARCA biopharma approves 1-for-12 reverse stock split","media":"seekingalpha","content":"<div>\n<p>Pharmaceutical company ARCA biopharma (NASDAQ:ABIO) said on Friday its board has approved a reverse stock split of its shares at a ratio of 1-for-12. ARCA’s (ABIO) stock is expected to begin trading ...</p>\n\n<a href=\"https://seekingalpha.com/news/4143514-arca-biopharma-approves-1-for-12-reverse-stock-split\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ARCA biopharma approves 1-for-12 reverse stock split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nARCA biopharma approves 1-for-12 reverse stock split\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-24 05:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4143514-arca-biopharma-approves-1-for-12-reverse-stock-split><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pharmaceutical company ARCA biopharma (NASDAQ:ABIO) said on Friday its board has approved a reverse stock split of its shares at a ratio of 1-for-12. ARCA’s (ABIO) stock is expected to begin trading ...</p>\n\n<a href=\"https://seekingalpha.com/news/4143514-arca-biopharma-approves-1-for-12-reverse-stock-split\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QLD","symbol_name":"纳指两倍做多ETF","start_time":0,"source_url":"https://seekingalpha.com/news/4143514-arca-biopharma-approves-1-for-12-reverse-stock-split","article_id":"2461037529","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1301873080/image_1301873080.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2461037529","pubTimestamp":1724449069,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Pharmaceutical company ARCA biopharma  said on Friday its board has approved a reverse stock split of its shares at a ratio of 1-for-12. ARCA’s  stock is expected to begin trading on a post-reverse stock split basis on the Nasdaq Global Market on September 3, 2024.  The company’s stock will trade under the new name Oruka Therapeutics, and under the new symbol “ORKA” after the closing of its merger with Oruka. The reverse stock split is expected to reduce ARCA ’s common shares from about 14.5M shares to about 1.2M shares. ARCA’s shares were down 3.85% during after-hours trading.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QLD":"纳指两倍做多ETF",".IXIC":"NASDAQ Composite","TQQQ":"纳指三倍做多ETF","BK4139":"生物科技","QID":"纳指两倍做空ETF","SQQQ":"纳指三倍做空ETF","PSQ":"纳指反向ETF"},"translate_title":"ARCA biopharma批准12股1股反向股票分割","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABIO":1,".IXIC":0.61,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"Pharmaceutical company ARCA biopharma (NASDAQ:ABIO) said on Friday its board has approved a reverse stock split of its shares at a ratio of 1-for-12. ARCA’s (ABIO) stock is expected to begin trading on a post-reverse stock split basis on the Nasdaq Global Market on September 3, 2024.  The company’s stock will trade under the new name Oruka Therapeutics, and under the new symbol “ORKA” after the closing of its merger with Oruka. The reverse stock split is expected to reduce ARCA (ABIO)’s common shares from about 14.5M shares to about 1.2M shares. ARCA’s shares were down 3.85% during after-hours trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2461037529"}